Severe bleeding as a result of platelet inhibition caused by floxacillin treatment for endocarditis.
Department of Anesthesiology and Intensive Care Medicine, Campus Charité Mitte and Campus Virchow-Klinikum, Charité-University Medicine Berlin, Berlin, Germany. Electronic address: juliane.rau@outlook.com.
Juliane
J
Rau
Mark
M
Simon
Michael
M
Sander
Christian
C
von Heymann
D000900:Anti-Bacterial Agents / Q000009:adverse effects*; D057915:Drug Substitution; D004697:Endocarditis, Bacterial / Q000175:diagnosis / Q000188:drug therapy* / Q000382:microbiology; D005436:Floxacillin / Q000009:adverse effects*; D006470:Hemorrhage / Q000097:blood / Q000139:chemically induced* / Q000175:diagnosis / Q000601:surgery; D006489:Hemostatic Techniques; D006801:Humans; D008297:Male; D055624:Methicillin-Resistant Staphylococcus aureus / Q000302:isolation & purification; D008875:Middle Aged; D010974:Platelet Aggregation / Q000187:drug effects*; D010979:Platelet Function Tests; D012720:Severity of Illness Index; D013203:Staphylococcal Infections / Q000175:diagnosis / Q000188:drug therapy* / Q000382:microbiology; D016896:Treatment Outcome
D000900:Anti-Bacterial Agents; D005436:Floxacillin
41.1